chr1-216885137-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000359162.6(ESRRG):​c.-14+54445G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.619 in 151,812 control chromosomes in the GnomAD database, including 29,662 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.62 ( 29662 hom., cov: 31)

Consequence

ESRRG
ENST00000359162.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.747

Publications

14 publications found
Variant links:
Genes affected
ESRRG (HGNC:3474): (estrogen related receptor gamma) This gene encodes a member of the estrogen receptor-related receptor (ESRR) family, which belongs to the nuclear hormone receptor superfamily. All members of the ESRR family share an almost identical DNA binding domain, which is composed of two C4-type zinc finger motifs. The ESRR members are orphan nuclear receptors; they bind to the estrogen response element and steroidogenic factor 1 response element, and activate genes controlled by both response elements in the absence of any ligands. The ESRR family is closely related to the estrogen receptor (ER) family. They share target genes, co-regulators and promoters, and by targeting the same set of genes, the ESRRs seem to interfere with the ER-mediated estrogen response in various ways. It has been reported that the family member encoded by this gene functions as a transcriptional activator of DNA cytosine-5-methyltransferases 1 (Dnmt1) expression by direct binding to its response elements in the DNMT1 promoters, modulates cell proliferation and estrogen signaling in breast cancer, and negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation and bone formation. Multiple alternatively spliced transcript variants have been identified, which mainly differ at the 5' end and some of which encode protein isoforms differing in the N-terminal region. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.682 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ESRRGNM_001134285.3 linkc.-14+54445G>A intron_variant Intron 3 of 8 NP_001127757.1 P62508-2F1D8R6
ESRRGNM_001243509.2 linkc.-14+54445G>A intron_variant Intron 3 of 8 NP_001230438.1 P62508-2F1D8R6C0SQ93
ESRRGNM_001243510.3 linkc.-131-19959G>A intron_variant Intron 2 of 8 NP_001230439.1 P62508-2F1D8R6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ESRRGENST00000359162.6 linkc.-14+54445G>A intron_variant Intron 2 of 7 1 ENSP00000352077.2 P62508-2
ESRRGENST00000361395.6 linkc.-131-19959G>A intron_variant Intron 1 of 7 1 ENSP00000354584.2 P62508-2
ESRRGENST00000366938.6 linkc.-190+54445G>A intron_variant Intron 1 of 7 1 ENSP00000355905.2 P62508-2

Frequencies

GnomAD3 genomes
AF:
0.619
AC:
93861
AN:
151694
Hom.:
29654
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.688
Gnomad AMI
AF:
0.804
Gnomad AMR
AF:
0.596
Gnomad ASJ
AF:
0.685
Gnomad EAS
AF:
0.261
Gnomad SAS
AF:
0.488
Gnomad FIN
AF:
0.658
Gnomad MID
AF:
0.665
Gnomad NFE
AF:
0.606
Gnomad OTH
AF:
0.597
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.619
AC:
93913
AN:
151812
Hom.:
29662
Cov.:
31
AF XY:
0.618
AC XY:
45840
AN XY:
74170
show subpopulations
African (AFR)
AF:
0.688
AC:
28450
AN:
41338
American (AMR)
AF:
0.596
AC:
9086
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.685
AC:
2378
AN:
3470
East Asian (EAS)
AF:
0.262
AC:
1347
AN:
5148
South Asian (SAS)
AF:
0.487
AC:
2344
AN:
4810
European-Finnish (FIN)
AF:
0.658
AC:
6946
AN:
10556
Middle Eastern (MID)
AF:
0.673
AC:
198
AN:
294
European-Non Finnish (NFE)
AF:
0.606
AC:
41188
AN:
67926
Other (OTH)
AF:
0.591
AC:
1246
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1752
3505
5257
7010
8762
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
752
1504
2256
3008
3760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.604
Hom.:
121508
Bravo
AF:
0.617
Asia WGS
AF:
0.377
AC:
1314
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
1.7
DANN
Benign
0.76
PhyloP100
-0.75
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1436900; hg19: chr1-217058479; API